Authors/Disclosures
|
Marina Boccardi, PhD
(IRCCS S.Giovanni Di Dio - Fatebenefratelli)
|
No disclosure on file |
|
|
No disclosure on file |
|
Liana Apostolova, MD, FAAN
(Indiana University School of Medicine)
|
Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. An immediate family member of Dr. Apostolova has stock in Cassava Neurosciences. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. |
|
|
No disclosure on file |
|
George Bartzokis, MD
|
No disclosure on file |
|
Tracy Durgin, PharmD
(Eisai)
|
No disclosure on file |
|
|
No disclosure on file |
|
Charles S. DeCarli, MD, FAAN
(UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center)
|
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Philippe Ryvlin, MD, PhD
(Unit 301)
|
Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe). |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Ronald J. Killiany, PhD
(Boston University School of Medicine)
|
Dr. Killiany has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Hilkka S. Soininen, MD, PhD
(University of Eastern Finland)
|
Dr. Soininen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. |
|
|
No disclosure on file |
|
Lei Wang, MD
(Texas Institute for neurology Disorders)
|
No disclosure on file |
|
Craig E. Watson, MD, PhD, FAAN
(UC Davis)
|
No disclosure on file |
|
|
No disclosure on file |
|
Simon Duchesne, PhD
(CRULRG)
|
Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care. |
|
Clifford R. Jack, Jr., MD
(Mayo Clinic)
|
The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. |
|
Giovanni B. Frisoni, MD
(Alzheimer's Unit IRCCS)
|
No disclosure on file |